Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin in T2DM with Coronary Artery Stenosis
NCT02266030Phase 3Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2011
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of cilostazol in coronary artery disease (CAD), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Coronary artery stenosis at 1 year. Started Feb 2011; status: completed.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02266030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266030.